{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-000518","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2026-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.519844+00:00","generated_at":"2026-05-16T11:33:38.472389+00:00","sec_items":["1.01","3.02","2.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aspire Biopharma converts ~$1.75M debt from PowerUp sponsors into common stock","bullets":["Exchanged ~$1.75M debt for common stock at closing price less $0.01/share; holders can submit up to 4 exchange notices by Jan 31, 2026.","Each exchange notice limited to 30% of outstanding balance; shares are freely tradeable without restrictive legends.","Upon a financing over $3M, company may repay debt; holder can elect 25% of outstanding balance from proceeds.","Exchange exempt under Section 3(a)(9) of Securities Act; debt originated from 2024 subscription agreements with PowerUp sponsors."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-000518","json":"https://secwatch.observer/filing/0001493152-26-000518.json","markdown":"https://secwatch.observer/filing/0001493152-26-000518.md","text":"https://secwatch.observer/filing/0001493152-26-000518.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226000518/0001493152-26-000518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226000518/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:33:38.472389+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f3ee1e4577c02ac48315b92b373529f6e57f2594","claim":"Aspire Biopharma Holdings, Inc. entered into Exchange Agreements with certain holders of the Company’s debt valued at approximately $1.75 million (effective 2026-01-01).","evidence_excerpt":"On January 1, 2026, the Company entered into Exchange Agreements (the “Exchange Agreements”) with certain holders of the Company’s debt (the “Holders”) to exchange approximately $1.75 million in debt for shares (the “Exchange Shares’) of the Company’s common stock (the “Exchange”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226000518/0001493152-26-000518-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"certain holders of the Company’s debt"},{"label":"Value","value":"approximately $1.75 million"},{"label":"Effective","value":"2026-01-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}